Stock Analysts

S&W Seed Stevia update (SANW)

Ian Gilson, CFA S&W Seed (SANW) Stevia update: The company has provided some news on Stevia. The first crop has been planted and leaf should be available for inventory and seed production later this year. The first shipments are expected in the December quarter, the second quarter of the 2012 fiscal year. […]

Stock Analysts

Q2 Results – Highlights Within the Numbers (TBIO)

Brian Marckx, CFA • Q2 RESULTS Transgenomic ( TBIO ) reported financial results for the second quarter ending June 30, 2011 on August 11th. While both revenue and net income/EPS missed our estimates by a wide margin, there were some highlights within the numbers and further detail provided on the conference call indicated that at least some of this "miss" will be recognized during Q3. As such, we would not characterize Q2 results as disappointing […]

Stock Analysts

Neutral on ANADIGICS (ANAD) (RIMM)

We maintain our recommendation on ANADIGICS, Inc ( ANAD ). ANADIGICS recently reported weak results in the second quarter of 2011. ANADIGICS reported net sales of $35.6 million in the second quarter of 2011, down 18.1% sequentially and down 31.1% from a year ago. […]

Stock Analysts

CIG’s 2Q up Y/Y, Down Sequentially (CIG) (ELP)

Companhia Energetica de Minas Gerais ( CIG ), known as CEMIG, reported encouraging results for the second quarter of 2011 as the company's net income rose 29% year over year to R$523 million (US$328.9 million), due primarily to higher revenue in the quarter. However, the results, though robust, were 0.6% below the previous quarter's income. Revenue Net revenue of the company escalated 11% year over year to R$3,820 million (US$2,402.5 million) and also registered a 5.4% sequential increase, due primarily to higher prices for electricity sold and higher demand […]

Stock Analysts

EpiCept is on track to achieve 2011 goals (EPCT)

Grant Zeng, CFA EpiCept ( EPCT ) Reports Second Quarter Results The Company recognized revenue of $0.2 million during the second quarter of 2011, compared with $0.3 million during the second quarter of 2010. For each of the second quarters of 2011 and 2010, revenue consisted primarily of the recognition of license fee payments previously received from strategic alliances, revenues from the sales of Ceplene to Meda and product royalties. […]

Stock Analysts

Investors Would be Wise to Look Beyond Armor Delays (ARTX)

Ken Nagy, CFA Investors Would be Wise to Look Beyond Armor Delays On August 15, 2011, Arotech Corporation ( ARTX ) , a provider of defense and security products, reported financial results for its fiscal 2011 second quarter, ended June 30, 2011. The second quarter performance resulted in a 24 percent year over year decrease in revenue, with revenue dropping $4.608 million to $14.296 million from $18.904 million for the three months ended June 30, 2010.Net income came in weak as well, falling $2.431 million year over year to a net loss of $2.071 million. This compares to net income of $360,000 million for the comparable quarter of 2010 […]